James S. Scibetta serves as Executive at Pacira Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, James S. Scibetta has executed 60 insider transactions totaling $11.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 30, 2013 involved exercising options for 10,000 shares valued at $16.1K.
James S. Scibetta currently holds 625,958 shares of Pacira Pharmaceuticals, Inc. (PCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James S. Scibetta has been a net seller of PCRX stock. They have purchased $435.5K and sold $10.9M worth of shares.
James S. Scibetta's most recent insider trade was on Dec 30, 2013, when they sold 10,000 shares at $1.61 per share.
Get notified when new Form 4 filings are submitted
| 10,000 |
| $1.61 |
| Discretionary |
| Sep 30, 2013 | PCRX | $467.4K | Sale | 10,000 | $46.74 | Discretionary |
| Aug 20, 2013 | NEPH | $0 | Award | 12,078 | $N/A | Discretionary |
| Jun 28, 2013 | PCRX | $280.5K | Sale | 10,000 | $28.05 | Discretionary |
| Jun 28, 2013 | PCRX | $16.1K | Option Exercise | 10,000 | $1.61 | Discretionary |
| May 23, 2013 | NEPH | $0 | Award | 52,056 | $N/A | Discretionary |
| Mar 28, 2013 | PCRX | $16.1K | Option Exercise | 10,000 | $1.61 | Discretionary |
| Mar 28, 2013 | PCRX | $284.9K | Sale | 10,000 | $28.49 | Discretionary |
| Feb 15, 2011 | PCRX | $35.2K | Purchase | 5,000 | $7.04 | Discretionary |